Abbott suspends 2020 guidance but keeps dividend

US healthcare company and dividend aristocrat Abbott Laboratories (ABT) announced its quarterly earnings of $0.65 per share, beating the estimated $0.58 per share. Net sales rose 2.5% to $7.73 billion, above the average estimate of $7.34 billion.

Abbott Laboratories has suspended its 2020 guidance but maintained its quarterly dividend as the corona pandemic has an impact on its business and the management is especially concerned about the duration of this period. Abbott is currently trading up 4% on the news. The current dividend yield is 1.62%.

We use cookies for a number of reasons, such as keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website are used. Accept & continue